Protective mechanisms of telmisartan against hepatic ischemia/reperfusion injury in rats may involve PPARγ-induced TLR4/NF-κB suppression
Author:
Publisher
Elsevier BV
Subject
Pharmacology,General Medicine
Reference79 articles.
1. Mechanisms of hepatic ischemia-reperfusion injury and protective effects of nitric oxide;Guan;World J. Gastrointest. Surg.,2014
2. Ischemia/reperfusion injury in liver surgery and transplantation: pathophysiology;Weigand;HPB Surg.,2012
3. Vildagliptin attenuates hepatic ischemia/reperfusion injury via the TLR4/NF-κB signaling pathway;Sherif;Oxid. Med. Cell Longev.,2018
4. Hepatic ischemia/reperfusion: mechanisms of tissue injury, repair, and regeneration;Konishi;Gene Expr.,2017
5. Angiotensin II, NADPH oxidase, and redox signaling in the vasculature;Nguyen Dinh Cat;Antioxid. Redox Signal,2013
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Deletion of protein kinase C θ attenuates hepatic ischemia/reperfusion injury and further elucidates its mechanism in pathophysiology;IRAN J BASIC MED SCI;2024
2. Protective effect of irbesartan against hepatic ischemia–reperfusion injury in rats: role of ERK, STAT3, and PPAR-γ inflammatory pathways in rats;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-08-21
3. Fangchinoline protects hepatic ischemia/reperfusion liver injury in rats through anti‐oxidative stress and anti‐inflammation properties: an in silico study;Biotechnology and Applied Biochemistry;2024-07-10
4. Mechanistic insight into the hepatoprotective effect of Moringa oleifera Lam leaf extract and telmisartan against carbon tetrachloride-induced liver fibrosis: plausible roles of TGF-β1/SMAD3/SMAD7 and HDAC2/NF-κB/PPARγ pathways;Drug and Chemical Toxicology;2024-06-04
5. Targeting NF-κB in Hepatic Ischemia–Reperfusion Alleviation: from Signaling Networks to Therapeutic Targeting;Molecular Neurobiology;2023-11-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3